Literature DB >> 2266426

Estrogen and progestin therapy to prevent osteoporosis: attitudes and practices of general internists and gynecologists.

G A Greendale1, K J Carlson, I Schiff.   

Abstract

STUDY
OBJECTIVE: To assess combined hormone therapy (CHT) prescribing patterns, possible impediments to CHT prescribing, and use of endometrial biopsy to monitor therapy.
DESIGN: Mailed questionnaire survey.
SUBJECTS: Gynecologists and general internists at two Boston teaching hospitals.
MEASUREMENTS AND MAIN RESULTS: Based on a 71% response rate, 72% of internists and 100% of gynecologists reported ever having prescribed CHT. Almost 60% of internists, compared with 8% of gynecologists, reported that over half of their female patients were older than 50 years of age. By logistic regression analysis of the internists' data, female gender of physician (odds ratio 11.0), belief that CHT decreases myocardial infarction risk (odds ratio 3.4), and knowledge of CHT's benefits and risks (odds ratio 2.8) were associated with prescribing. Endometrial biopsy was performed by a majority of physicians only when unexpected vaginal bleeding occurred and in cases of unclear menopausal transition. Physicians who were concerned about litigation were seven times more likely to perform baseline endometrial biopsy.
CONCLUSIONS: In the authors' sample, as well as nationally, internists are more likely to provide care for menopausal women. Among internists, gender and knowledge are strongly associated with CHT prescribing. These findings have important educational implications if internists are to routinely provide information and counseling to women about osteoporosis and CHT.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2266426     DOI: 10.1007/bf02600870

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  12 in total

1.  Risk of localized and widespread endometrial cancer in relation to recent and discontinued use of conjugated estrogens.

Authors:  S Shapiro; J P Kelly; L Rosenberg; D W Kaufman; S P Helmrich; N B Rosenshein; J L Lewis; R C Knapp; P D Stolley; D Schottenfeld
Journal:  N Engl J Med       Date:  1985-10-17       Impact factor: 91.245

2.  A simple method for determining the optimal dosage of progestin in postmenopausal women receiving estrogens.

Authors:  M L Padwick; J Pryse-Davies; M I Whitehead
Journal:  N Engl J Med       Date:  1986-10-09       Impact factor: 91.245

3.  National trends in the use of preventive health care by women.

Authors:  D M Makuc; V M Freid; J C Kleinman
Journal:  Am J Public Health       Date:  1989-01       Impact factor: 9.308

4.  Estrogen replacement therapy. A survey of women's knowledge and attitudes.

Authors:  K J Ferguson; C Hoegh; S Johnson
Journal:  Arch Intern Med       Date:  1989-01

5.  Physicians' judgments about estrogen replacement therapy for menopausal women.

Authors:  G B Holzman; M M Ravitch; W Metheny; M L Rothert; M Holmes; R B Hoppe
Journal:  Obstet Gynecol       Date:  1984-03       Impact factor: 7.661

6.  Hysterectomy and sex of the gynecologist.

Authors:  G Domenighetti; P Luraschi; A Marazzi
Journal:  N Engl J Med       Date:  1985-12-05       Impact factor: 91.245

Review 7.  Physician gender and the physician-patient relationship: recent evidence and relevant questions.

Authors:  C S Weisman; M A Teitelbaum
Journal:  Soc Sci Med       Date:  1985       Impact factor: 4.634

8.  Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study.

Authors:  D P Kiel; D T Felson; J J Anderson; P W Wilson; M A Moskowitz
Journal:  N Engl J Med       Date:  1987-11-05       Impact factor: 91.245

9.  Delivery of fertility control services by male and female obstetrician-gynecologists.

Authors:  C S Weisman; C A Nathanson; M A Teitelbaum; G A Chase; T M King
Journal:  Am J Obstet Gynecol       Date:  1987-02       Impact factor: 8.661

10.  Postmenopausal estrogens in prevention of osteoporosis. Benefit virtually without risk if cardiovascular effects are considered.

Authors:  B E Hillner; J P Hollenberg; S G Pauker
Journal:  Am J Med       Date:  1986-06       Impact factor: 4.965

View more
  8 in total

Review 1.  Hormone replacement therapy: I. A pharmacoeconomic appraisal of its therapeutic use in menopausal symptoms and urogenital estrogen deficiency.

Authors:  R Whittington; D Faulds
Journal:  Pharmacoeconomics       Date:  1994-05       Impact factor: 4.981

Review 2.  Postmenopausal hormone replacement: are two hormones better than one?

Authors:  H Wood; R Wang-Cheng; A B Nattinger
Journal:  J Gen Intern Med       Date:  1993-08       Impact factor: 5.128

3.  Gynecologists' sex, clinical beliefs, and hysterectomy rates.

Authors:  N A Bickell; J A Earp; J M Garrett; A T Evans
Journal:  Am J Public Health       Date:  1994-10       Impact factor: 9.308

4.  Effect of physician gender on the prescription of estrogen replacement therapy.

Authors:  T B Seto; D A Taira; R B Davis; C Safran; R S Phillips
Journal:  J Gen Intern Med       Date:  1996-04       Impact factor: 5.128

5.  Prevalence and duration of postmenopausal hormone replacement therapy use in a managed care organization, 1990-1995.

Authors:  M T Connelly; M Richardson; R Platt
Journal:  J Gen Intern Med       Date:  2000-08       Impact factor: 5.128

6.  Hormone replacement therapy: a survey of Ontario physicians' prescribing practices.

Authors:  L Elinson; M M Cohen; T Elmslie
Journal:  CMAJ       Date:  1999-09-21       Impact factor: 8.262

7.  Assessing the needs of women and clinicians for the management of menopause in an HMO.

Authors:  W W Livingston; J M Healy; H S Jordan; C K Warner; J L Zazzali
Journal:  J Gen Intern Med       Date:  1994-07       Impact factor: 5.128

8.  Changes of the prescription of hormone therapy in menopausal women: an observational study in Taiwan.

Authors:  Weng-Foung Huang; Yi-Wen Tsai; Fei-Yuan Hsiao; Wen-Chun Liu
Journal:  BMC Public Health       Date:  2007-04-17       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.